DarioHealth Corporation (DRIO) 뉴스

Looking good today $1.23 + 50%
NEW YORK--(BUSINESS WIRE)--Jan. 14, 2025--Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The company’s latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a larger share of this lucrative space as demand for medical weight-loss solutions skyrockets across employers and consumers. Following the announcement, Dario’s shares surged nearly 14%, reflecting investor excitement over this significant growth opportunity.The market for GLP-1 medications, driven by blockbuster drugs like Novo Nordisk’s Ozempic and Wegovy, is transforming how obesity and weight management are addressed. These medications have shown impressive results, leading to double-digit weight loss, but the rising costs are pushing employers to seek solutions that ensure better ROI. With 44% of large employers now covering obesity medications, according to a recent Mercer survey, Dario’s expanded offering provides an end-to-end program to improve employee health outcomes while managing costs.Unlike many digital health providers, Dario’s solution integrates behavior change programs with physician oversight, ensuring that GLP-1 medications are prescribed to the right people and supported by sustainable lifestyle changes. This approach aims to prevent the all-too-common cycle of weight regain after medication use, a key concern for both individuals and employers. The new prescribing capability is a critical piece of the puzzle, enabling Dario to oversee the entire weight-loss journey and optimize long-term results.Beyond employers, the direct-to-consumer market is another high-growth target for Dario. As more consumers seek out medical weight-loss options online, the company’s digital platform, combined with virtual care, offers an easily accessible, scalable solution to meet this demand. Additionally, pharmaceutical companies are increasingly seeking partners like Dario to provide data-driven insights and improve patient engagement, opening potential new revenue streams.Dario’s move follows the success of GLP-1 giants Novo Nordisk and Eli Lilly, whose treatments have reshaped the market. However, while the market leaders focus on medications alone, Dario’s behavior-first model differentiates it by tackling the underlying habits that drive lasting weight loss.As the GLP-1 market continues to expand, Dario’s integrated solution could position the company as a key digital health partner for employers, consumers, and pharma companies alike—tapping into one of healthcare’s most promising opportunities for growth.Market Alerts are generated by Wall Street Wire’s news desk and summarize news developments. They include partner content on behalf of the mentioned issuer [DRIO]. They are not intended to serve as financial or investment advice. Please see our full terms, disclaimers and compensation disclosures here: redditwire.com/terms. Our alerts may include forward looking statements about the significance or impact an announcement or development may have on the future of a company or industry as well as other similar statements which may not come to fruition. We advise all readers refer to our full terms in the above link.View source version on businesswire.com: https://www.businesswire.com/news/home/20250114486200/en/Market Alerts News Desk
media.globalmarkets@gmail.com

$25??? How did tht work out for u

I know, I add 3000 shares today and hope it's gonna stay that level for me tomorrow to add more.

wow look at DRIO, it totally collapsed, I ended up doing pretty decent considering its fall from grace even down to 3 bucks, but, the scary part is had I had enough free cash to buy back in from say $3 to $1 I would probably have done so, this is just utter devastation of a stock that has real revenues and real impact on peoples lives, I literally cannot believe it. At a buck it sure seems like a friggin steal

well some of those calls finished in the money over 5 bucks and I was called out, perfect, continuing with the Dec options. Granted the DRIO options dont give a ton of premium considering the potential in the stock from where it has fallen, but so be it, if you buy the stock cheap then it just doesnt matter. DRIO is a good trade down here.

DRIOs been a tough trade for the last 10 months or so, but still have been able to make a few bucks overall, the stock long term is oversold compared to the rest of the market. Most recently I wrote the 5.0 calls for Oct and Nov hoping for them to go out worthless, but even if not, it will be profit if I am called out anywhere in the money. In this market you need to take profits as they come, and writing the options can be good. I would even consider writing the $5 puts, though all of this takes valuable margin so need to be prudent.

DRIO has had a nice run and I have taken a lot off the table. In a market like this, need to shift things around especially on upside like this in a short period, can always re-enter if it pulls back significantly.

wow DRIO has really tanked, imagine from the 30s down to 5 dollar range, wow. I have done some trading and have an average around 7.50 since first purchase at 12.65, not bad, but you can never pick the bottom of any of these they always go further than you think is possible, I am fine with that. DRIO at 6 bucks is a great price.

Trading DRIO again, starting at 10 bucks, it's an excellent price under 8 and i will definitely try and accumulate at these levels.

Wow DRIO is an absolute steal at these prices. I dont have the money to put in this second, but I would certainly consider it.

Looking to gain today.

Brilliant acquisition of Upright that further differentiates DRIO from competitors such as Livongo.

Market has not yet appreciated the value of adding the leading MSK platform to DRIO's own platform.

The concurrent investment by leading bioscience institutional investors, such as Perceptive, at market price, is also very positive news, and further validates the value and potential of this company.

One more time bought back in the 16s avg and sold off everything as of today, I am done with DRIO unless it has another decent pullback, dont know if it will or not. There was a ton of money to be made on DRIO, I did ok but could have done a lot lot better considering how long I had been in it, but I'll take it.

sold my last shares at $20, DRIO has been good to me, but definitely had to persevere and trade, though had I just held I would have done better than all the trading machinations. This no longer is a penny stock and so holding it has less huge potential in my opinion. But any large pullbacks starting around here I am willing to dabble and buy some back in.

Not really...

I’d hold and hope for another pop. Several are pumping it on Twitter.

Question on DRIOW?!?

I purchased DRIOW last week at $0.43 average share price. I won 41808 shares at this average.

When I reached out to IR they said that the effective share price is $86.60 due to the 20 to 1 Reverse split in November of 2019.

I'd like to understand if I should cut my losses (made a mistake did not do my DD and thought this was common stock and not Warrants) and sell now or if this will work in my favor?

Thanks for the help!

DRIO is going to $25 in Jan. and DRIOW going to $3.

DRIOW was even high as $1.2 some time ago. LOL!

DRIOW, went high as $0.56 this morning. Amazing!!!

Sold some DRIOW (bought at $0.05 ) for 500% profits and leave the free shares to run.

Bought bunches DRIOW at $0.04-0.05, now 500% gains !!!!!

WOOHOOOOOOO DRIOW$$ LMFAO WOOHOOOOOOOO

News: $DRIO BioMedNewsBreaks - DarioHealth Corp. (NASDAQ: DRIO) Taking Health Care Home Through Innovative Platform

DarioHealth (NASDAQ: DRIO) , a global digital-therapeutics company serving its users with dynamic mobile-health solutions, is a clear point-of-need innovator in today’s standoffish environment. The company supplies hospitals with next-generation technology to provide patients necessary...

Got this from DRIO - BioMedNewsBreaks - DarioHealth Corp. (NASDAQ: DRIO) Taking Health Care Home Through Innovative Platform

News: $DRIO NetworkNewsBreaks - Shares of DarioHealth Corp. (NASDAQ: DRIO) Reach 52-Week High

Shares of DarioHealth Corp. (NASDAQ: DRIO) , a pioneer in the global digital therapeutics market, reached a new 52-week high on Wednesday. In morning trading, the company’s shares reached a peak of $22.49 on volume of over 170,000, up from an opening price of $18.75. At time of publish...

Read the whole news DRIO - NetworkNewsBreaks - Shares of DarioHealth Corp. (NASDAQ: DRIO) Reach 52-Week High

Shouldn't the warrants be worth at least $5 WOOHOOOOOOOOOOOOOOO DRIO $28 TARGET price

News: $DRIO BioMedNewsBreaks - Aegis Capital Corp. Initiates Coverage, Issues 'Buy' Rating on DarioHealth Corp. (NASDAQ: DRIO)

Aegis Capital Corp. has initiated coverage with a ‘Buy’ rating and price target of $25 on shares of DarioHealth’s (NASDAQ: DRIO) stock. DRIO is a pioneer in the global digital therapeutics (“DTx”) industry with its popular, smartphone-centered personalize...

In case you are interested DRIO - BioMedNewsBreaks - Aegis Capital Corp. Initiates Coverage, Issues 'Buy' Rating on DarioHealth Corp. (NASDAQ: DRIO)

Big Move upcoming WOOHOOOOOOOOOOOOOOO DRIO DRIOW

woohooooooooooooooo

DRIO $28 TARGET PRICE WOOHOOOOOOOOOOOOOOO

DRIO $28 TARGET PRICE WOOHOOOOOOOOOOOOOOO

2021

Warrant way too cheap DRIOW

Hey,
im interested in the Drio Warrants does anyone know the Terms of Warrants, Exercise price and Expiration date.

$$$$$$$

I got some of the warrant
Wayyy undervalued

DRIOW warrant

This move is huge WOW!

WOW!NICE

DRIO WOOHOOOOOOOOOOOOOOOO

DRIOW

What are the warrants?

This is incredible if the warrants take off that would be awesome WoW!

Any reason why warrants are not moving

News: $DRIO DarioHealth Announces $28.6 Million Private Placement

NEW YORK , July 31, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including healthcare funds and institutions from the U.S. and Israel ....

In case you are interested DRIO - DarioHealth Announces $28.6 Million Private Placement

News: $DRIO 6 Factors Fueling Antimicrobial Resistance

Drug resistance is a serious medical concern and poses a severe health threat in the medical fraternity. In this regard, antimicrobial resistance is one of the worst nightmares that most patients suffering from various infections continue to grapple with across the world. Generally, antimicr...

In case you are interested DRIO - 6 Factors Fueling Antimicrobial Resistance

I'm here nothing about reverse stock split stock is up big time

Here we go again... reverse split in the future

DRIOW I think they're worth at least $1 WOW!

DRIO$ $10 TARGET PRICE